top of page
AUS-REISAMIC
the Australian Registry for Evaluation of Immune-related Severe Adverse Events from Monoclonal antibody Immune Checkpoint inhibitors:
a registry for rheumatic immune-related adverse events in Australia
A national multi-centre initiative based at Austin Health, Melbourne
in collaboration with REISAMIC
(Registre des effets indésirables sévères des anticorps monoclonaux immunomodulateurs en cancérologie),
based at Institut Gustave Roussy, Villejuif, France
bottom of page